NASDAQ:HQY - Healthequity Stock Price, News, & Analysis

$70.71
+0.76 (+1.09 %)
(As of 06/17/2019 04:00 PM ET)
Today's Range
$69.80
Now: $70.71
$71.99
50-Day Range
$63.04
MA: $68.85
$72.93
52-Week Range
$50.29
Now: $70.71
$101.58
Volume402,924 shs
Average Volume884,462 shs
Market Capitalization$4.44 billion
P/E Ratio74.43
Dividend YieldN/A
Beta1.55
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. Read More…

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HQY
CUSIPN/A
Phone801-727-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$287.24 million
Cash Flow$1.2652 per share
Book Value$7.65 per share

Profitability

Net Income$73.90 million

Miscellaneous

Employees1,141
Market Cap$4.44 billion
Next Earnings Date9/3/2019 (Estimated)
OptionableOptionable

Receive HQY News and Ratings via Email

Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter.

Healthequity (NASDAQ:HQY) Frequently Asked Questions

What is Healthequity's stock symbol?

Healthequity trades on the NASDAQ under the ticker symbol "HQY."

How were Healthequity's earnings last quarter?

Healthequity Inc (NASDAQ:HQY) posted its quarterly earnings results on Tuesday, June, 4th. The company reported $0.36 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.25 by $0.11. The company had revenue of $87.05 million for the quarter, compared to the consensus estimate of $83.98 million. Healthequity had a net margin of 30.60% and a return on equity of 14.17%. View Healthequity's Earnings History.

When is Healthequity's next earnings date?

Healthequity is scheduled to release their next quarterly earnings announcement on Tuesday, September 3rd 2019. View Earnings Estimates for Healthequity.

What guidance has Healthequity issued on next quarter's earnings?

Healthequity issued an update on its FY20 earnings guidance on Tuesday, June, 4th. The company provided EPS guidance of $1.28-1.34 for the period, compared to the Thomson Reuters consensus estimate of $1.28. The company issued revenue guidance of $339-345 million, compared to the consensus revenue estimate of $337.55 million.Healthequity also updated its FY 2020 guidance to $1.28-1.34 EPS.

What price target have analysts set for HQY?

11 Wall Street analysts have issued twelve-month price objectives for Healthequity's shares. Their forecasts range from $75.00 to $102.00. On average, they expect Healthequity's share price to reach $88.0909 in the next twelve months. This suggests a possible upside of 24.6% from the stock's current price. View Analyst Price Targets for Healthequity.

What is the consensus analysts' recommendation for Healthequity?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Healthequity.

What are Wall Street analysts saying about Healthequity stock?

Here are some recent quotes from research analysts about Healthequity stock:
  • 1. According to Zacks Investment Research, "Strong growth in Service and Custodial revenue segments buoy optimism HealthEquity. Notably, solid growth in HSAs and custodial assets provided a boost to the company’s top-line performance. Currently, HealthEquity is the second-largest HSA custodian in terms of market share. These apart, HealthEquity’s 401(K) solution, which lowers the cost, risk and work of managing a retirement plan, bodes well for the company. Moreover, management is optimistic about the launch of HealthEquity retirement services. Reflective of the trends exhibited by the company, the stock outperformed its industry year to date. On the flip side, HealthEquity faces stiff competition in Medical Services markets. HealthEquity is required to comply with strict Treasury Regulations formulated by the Internal Revenue Service or the IRS." (5/21/2019)
  • 2. Cantor Fitzgerald analysts commented, ". We are upgrading the shares of from Neutral. Our price target remains $82, or roughly 38% above current levels. HQY shares have struggled since the company reported F3Q19 results earlier this month. We believe fundamentals remain strong as HQY continues to benefit from continued adoption of health savings accounts (HSA). The company continues to grow above market rates. In the most recent quarter, HQY’s HSA members grew by 22%, which compares with Webster Bank, which reported account growth of just 12%. Earnings continue to benefit from a higher interest environment, even with a slight moderation in 10-year interest rates lately." (12/17/2018)

Has Healthequity been receiving favorable news coverage?

News stories about HQY stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Healthequity earned a coverage optimism score of 1.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Healthequity.

Who are some of Healthequity's key competitors?

What other stocks do shareholders of Healthequity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Healthequity investors own include Input Capital (INP), Circle Oil (COP), Falcon Oil & Gas (FO), Shopify (SHOP), Ivanhoe Mines (IVN), NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), Netflix (NFLX) and Paypal (PYPL).

Who are Healthequity's key executives?

Healthequity's management team includes the folowing people:
  • Mr. Jon Kessler, Pres, CEO & Director (Age 51)
  • Stephen D. Neeleman, Founder & Vice Chairman (Age 51)
  • Mr. Darcy G. Mott, Exec. VP & CFO (Age 66)
  • Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 46)
  • Mr. William Robert Otten, Exec. VP of Sales (Age 54)

Who are Healthequity's major shareholders?

Healthequity's stock is owned by many different of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.29%), FMR LLC (4.58%), Wasatch Advisors Inc. (3.26%), Janus Henderson Group PLC (2.89%), Jackson Square Partners LLC (2.78%) and Wells Fargo & Company MN (1.54%). Company insiders that own Healthequity stock include Angelique Christine Hill, Ashley Dreier, Berkley Capital, Llc, Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino, Frank Medici, Gary D Robinson, Jon Kessler, Jon Soldan and Stephen Neeleman. View Institutional Ownership Trends for Healthequity.

Which institutional investors are selling Healthequity stock?

HQY stock was sold by a variety of institutional investors in the last quarter, including Janus Henderson Group PLC, FMR LLC, Eagle Asset Management Inc., BlackRock Inc., Carillon Tower Advisers Inc., OppenheimerFunds Inc., Stephens Investment Management Group LLC and Bank of Montreal Can. Company insiders that have sold Healthequity company stock in the last year include Darcy G Mott, Delano Ladd, Evelyn S Dilsaver, Frank Corvino and Frank Medici. View Insider Buying and Selling for Healthequity.

Which institutional investors are buying Healthequity stock?

HQY stock was bought by a variety of institutional investors in the last quarter, including Jackson Square Partners LLC, Wasatch Advisors Inc., Wells Fargo & Company MN, American Capital Management Inc., Moody Lynn & Lieberson LLC, Kayne Anderson Rudnick Investment Management LLC, Kayne Anderson Rudnick Investment Management LLC and TimesSquare Capital Management LLC. View Insider Buying and Selling for Healthequity.

How do I buy shares of Healthequity?

Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Healthequity's stock price today?

One share of HQY stock can currently be purchased for approximately $70.71.

How big of a company is Healthequity?

Healthequity has a market capitalization of $4.44 billion and generates $287.24 million in revenue each year. The company earns $73.90 million in net income (profit) each year or $0.95 on an earnings per share basis. Healthequity employs 1,141 workers across the globe.View Additional Information About Healthequity.

What is Healthequity's official website?

The official website for Healthequity is http://www.healthequity.com/.

How can I contact Healthequity?

Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected]


MarketBeat Community Rating for Healthequity (NASDAQ HQY)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  348 (Vote Outperform)
Underperform Votes:  277 (Vote Underperform)
Total Votes:  625
MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote "Outperform" if you believe HQY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel